So it seems (and I have no way of checking) that some CVPR submissions are being trailed in the New York Times the day after the submission deadline.
The implication is that the authors and the community are in favour of abandoning double-blind review.
The problem is, though, that this is not our choice to make. By “our” here, I mean those of us who are famous authors at famous institutions. Bigshots if you will. Of course, there are arguments for and against double-blind, but we (the bigshots) are those whom it is designed to protect against, so if we unilaterally abandon it, we strengthen any case for its existence.
Note that this is not a question of what the CVPR conference chairs decided. This is a decision each individual makes when they post their unblinded paper on any indexed website.